photomirex: major photodecomposition product of mirex (dodecachloro)
ID Source | ID |
---|---|
PubMed CID | 91632 |
SCHEMBL ID | 3500657 |
MeSH ID | M0066824 |
Synonym |
---|
39801-14-4 |
mirex, photo- |
1,1a,2,2,3,3a,4,5,5,5a,5b-undecachlorooctahydro-1h-1,3,4-(methanetriyl)cyclobuta[cd]pentalene |
8-monohydro mirex |
1,3,4-metheno-1h-cyclobuta(cd)pentalene, 1,1a,2,2,3,3a,4,5,5,5a,5-undecachlorooctahydro- |
1,2,3,4,5,5,6,7,9,10,10- undecachloropentacyclo(5.3.0.0.0.0)decane |
1,2,3,4,5,5,6,7,9,10,10-undecachloropentacyclo(5.3.0.0(sup 2,6).0(sup 3,9).0(sup 4,8))decane |
photomirex |
hydromirex |
8-monohydromirex |
photomirex (~90%) |
8-hydromirex |
1,1a,2,2,3,3a,4,5,5,5a,5b-undecachlorooctahydro-1,3,4-metheno-1h-cyclobuta[cd]pentalene |
unii-g7c95qe27q |
g7c95qe27q , |
1,3,4-metheno-1h-cyclobuta(cd)pentalene, 1,1a,2,2,3,3a,4,5,5,5a,5b-undecachlorooctahydro- |
FT-0673872 |
SCHEMBL3500657 |
1,3,4-metheno-1h-cyclobuta[cd]pentalene, 1,1a,2,2,3,3a,4,5,5,5a,5b-undecachlorooctahydro- |
DTXSID2020896 |
AKOS030254545 |
photomirex (~90per cent) |
1,2,3,4,5,5,6,7,9,10,10-undecachloropentacyclo[5.3.0.02,6.03,9.04,8]decane |
Photomirex was approximately five times more toxic than mirex in terms of liver histology. In all cases, the cumulative LD50 for photomireX was estimated as 225-250 mg/kg.
Excerpt | Reference | Relevance |
---|---|---|
" These results indicate that photomirex was approximately five times more toxic than mirex in terms of liver histology." | ( Subchronic toxicity of photomirex in the female rat: results of 28- and 90-day feeding studies. Becking, GC; Chu, I; Secours, V; Sundaram, A; Villeneuve, DC, 1980) | 0.86 |
" In all cases, the cumulative LD50 for photomirex was estimated as 225-250 mg/kg." | ( Assessment of photomirex toxicity in the mouse. Fujimori, K; Ho, IK; Mehendale, HM, 1980) | 0.89 |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 13 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (16.69) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 18 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |